Advances in immunotherapy for the treatment of glioblastoma Amanda TivnanTatjana HeilingerJochen H. M. Prehn Topic Review Open access 14 October 2016 Pages: 1 - 9
Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses Siobhan ConroyMichiel WagemakersWilfred F. A. den Dunnen Laboratory Investigation Open access 15 September 2016 Pages: 11 - 20
Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma Yuelong WangJiaojiao DengLiangxue Zhou Laboratory Investigation 17 September 2016 Pages: 21 - 29
Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway Yufu ZhuZhichao QiuRutong Yu Laboratory Investigation 17 September 2016 Pages: 31 - 39
Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma C. KurokawaH. GeekiyanageE. Galanis Laboratory Investigation 05 November 2016 Pages: 41 - 48
Characterization of the distribution, retention, and efficacy of internal radiation of 188Re-lipid nanocapsules in an immunocompromised human glioblastoma model Annabelle CikankowitzAnne ClavreulFrançois Hindré Laboratory Investigation 25 October 2016 Pages: 49 - 58
Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis Aditya V. KarhadeLuis FandinoTimothy R. Smith Clinical Study 18 November 2016 Pages: 59 - 67
Preliminary experience of the concurrent use of radiosurgery and T-DM1 for brain metastases in HER2-positive metastatic breast cancer Arthur GeraudHao Ping XuYoulia M. Kirova Clinical Study 19 December 2016 Pages: 69 - 72
Radiosurgical decompression for benign perioptic tumors causing compressive cranial neuropathies: a feasible alternative to microsurgery? Eun Jung LeeYoung Hyun ChoSung Woo Roh Clinical Study 06 September 2016 Pages: 73 - 81
Radiotherapy induces an immediate inflammatory reaction in malignant glioma: a clinical microdialysis study Pedram TabatabaeiEward VisseA. Tommy Bergenheim Clinical Study Open access 23 September 2016 Pages: 83 - 92
In vivo molecular profiling of human glioma using diffusion kurtosis imaging Johann-Martin HempelSotirios BisdasUwe Klose Clinical Study 07 September 2016 Pages: 93 - 101
Erratum to: In vivo molecular profiling of human glioma using diffusion kurtosis imaging Johann-Martin HempelSotirios BisdasUwe Klose Erratum 22 September 2016 Pages: 103 - 103
Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study Pierre ChabotTe-Chun HsiaJohn H. Suh Clinical Study Open access 21 September 2016 Pages: 105 - 115
Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort Katrina A. MorrisJohn F. GoldingOn behalf of the UK NF2 research group Clinical Study 28 October 2016 Pages: 117 - 124
Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis Akshitkumar M. MistryAndrew T. HaleRebecca A. Ihrie Clinical Study 19 September 2016 Pages: 125 - 133
Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting Anne-Katrin HickmannMarlene HechtnerMirjam Renovanz Clinical Study 16 September 2016 Pages: 135 - 151
Analyses of prognosis-related factors of intracranial solitary fibrous tumors and hemangiopericytomas help understand the relationship between the two sorts of tumors Lingcheng ZengYan WangTing Lei Clinical Study 26 September 2016 Pages: 153 - 161
Incidence, time trends and survival patterns of childhood pilocytic astrocytomas in Southern-Eastern Europe and SEER, US Marios K. GeorgakisMaria A. KaralexiEleni Th. Petridou Clinical Study 14 October 2016 Pages: 163 - 175
Stereotactic radiosurgery for non-vestibular cranial nerve schwanommas Myreille D’AstousAllen L. HoSteven D. Chang Clinical Study 17 October 2016 Pages: 177 - 183
Phase II study of MEDI-575, an anti-platelet-derived growth factor-α antibody, in patients with recurrent glioblastoma Surasak PhuphanichJeffrey RaizerKevin Laubscher Clinical Study 14 November 2016 Pages: 185 - 191
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma Mark R. GilbertStephanie L. PughMinesh Mehta Clinical Study 21 October 2016 Pages: 193 - 199